Dr. Gang Huang to Present at the 2025 La Frontera Symposium on Immunological Advances in the Tumor Microenvironment
SAN ANTONIO, TEXAS — The Huang Laboratory at UT Health San Antonio is proud to announce that Dr. Gang Huang, Professor in the Department of Cell Systems and Anatomy and faculty member of the Mays Cancer Center, will present his latest work on PH102 at the upcoming La Frontera Symposium, hosted by the Long School of Medicine’s Office for Research.
This year’s symposium, themed “Immunological Advances in the Tumor Microenvironment,” will bring together leading scientists in cancer biology and immunology to discuss cutting-edge approaches that reshape our understanding of immune regulation in cancer progression and therapy resistance. The event will be co-hosted by Drs. Laurence Morel, Nu Zhang, Lei Zheng, and Tim Huang, and organized in collaboration with the Departments of Microbiology, Immunology and Molecular Genetics, Molecular Medicine, and the Mays Cancer Center.
Dr. Huang’s presentation will focus on PH102, a GPC3-targeted CAR T-cell therapy developed to overcome the barriers that have historically limited the success of cellular immunotherapies in solid tumors. His talk will highlight recent preclinical findings demonstrating how PH102 reprograms the tumor immune microenvironment (TiME) through multi-pathway targeting and immune activation, leading to improved infiltration, persistence, and anti-tumor efficacy against hepatocellular carcinoma (HCC).
In addition to Dr. Huang, the symposium will feature presentations from Dr. Josephine Taverna, Dr. Chia-Nung Hung, Dr. Manjeet Rao, and keynote speaker Dr. Drew Pardoll, Distinguished Professor at Johns Hopkins Medicine and a global leader in cancer immunology and translational immunotherapy.
Dr. Huang’s presentation underscores UT Health San Antonio’s growing leadership in cell-based immunotherapies and the Mays Cancer Center’s mission to develop next-generation precision immunotherapies for both solid tumors and hematologic cancers through interdisciplinary collaboration and innovation.
About the Huang Lab
The Huang Lab at UT Health San Antonio is a basic and translational cancer research group within the MD Anderson Mays Cancer Center at UT Health San Antonio. Our team integrates hematology and solid tumor biology with immunology and metabolism to uncover mechanisms and design interventions. We advance cell and biologic therapies, including CAR T‑cell approaches for solid tumors. We also conduct research in trauma and military health. We move discoveries toward clinical impact through product development and collaborations with clinicians and industry. Education and mentorship are core to our mission. We train students, postdoctoral fellows, and early‑career scientists in rigorous, multidisciplinary research. Together, we aim to deliver therapies and technologies that improve patient outcomes.